Mirtazapine Flas Normogen (Mirtazapine)

Mirtazapine works by blocking presynaptic α2‑adrenergic receptors, which increases the release of norepinephrine, and by antagonizing postsynaptic 5‑HT2 and 5‑HT3 receptors while stimulating 5‑HT1 receptors. This dual action enhances both noradrenergic and serotonergic neurotransmission, contributing to mood improvement and reduced anxiety.

The appropriate dose of mirtazapine is determined by the prescribing clinician based on the individual’s clinical condition, response, and tolerability. Initial dosing typically starts at a low level and may be adjusted upward as needed, but exact amounts should only be set by a qualified healthcare professional.

Safety data for mirtazapine during pregnancy and lactation are limited. It should only be used if the potential benefit justifies any possible risk to the fetus or infant. Healthcare providers usually evaluate the risk‑benefit profile carefully before prescribing to pregnant or nursing women.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Mirtazapine differs from many selective serotonin reuptake inhibitors (SSRIs) by its dual antagonism of α2‑adrenergic and specific serotonin receptors, which often results in pronounced sedative and appetite‑stimulating effects. This profile can be advantageous for patients with insomnia or weight loss, whereas SSRIs may have a lower risk of sedation but can cause different side‑effect patterns.

Store the product at ambient temperature, preferably below 25 °C. Keep it in the original packaging to protect it from moisture and light. Do not refrigerate or freeze the medication, and ensure the container is tightly closed when not in use.

Mirtazapine Flas Normogen is taken orally, usually once daily in the evening due to its sedative properties. The tablet (or other oral form) should be swallowed whole with water and not chewed or crushed unless otherwise directed by a healthcare professional.

Serious risks include the potential for agranulocytosis, severe neutropenia, and hepatotoxicity. Patients should be monitored for signs of infection, unexplained fever, or liver dysfunction. Immediate medical attention is required if any of these serious adverse events are suspected.

Mirtazapine should be avoided in individuals who have a known hypersensitivity to the drug or any of its components. It is also contraindicated in patients currently taking monoamine oxidase inhibitors (MAOIs) without an appropriate washout period, and caution is advised for those with severe hepatic impairment.